An observational study in Renal Colic and Urolithiasis, sponsored by Mikolaj Przydacz. Active, not recruiting at 1 site in Poland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-11.
Sponsored by Mikolaj Przydacz · Observational
The aim of this study is to analyze the prevalence, effect on quality of life, and treatment-related behaviors for renal colic and urolithiasis in a population-representative sample of Poles. We will be using an Internet interview format for renal colic and urolithiasis evaluation. The study will include respondents representative for age and place of residence with adequate proportions of respondents from urban and rural areas.
79 studies on the registry are indexed under Renal Colic; 10 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 452 across 16 observational studies indexed under Renal Colic.
Browse Renal Colic studies →This is the only study on the registry with Mikolaj Przydacz as lead sponsor.
Counted across the registry records on this site, refreshed daily.
A representative pool of men and women in Poland
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: No intervention
No intervention
Prevalence of renal colic and urolithiasis in Poland
Prevalence of renal colic and urolithiasis in Poland
Time frame: December 2023 - December 2024
Plan to share: No
Ran from Dec 2023 to primary completion in Jun 2024, 6 months.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.